Table 1.
Top ranked variables at the root node
| Predictors | Abstinence | Abstinence from heavy drinking | 2-level reduction in WHO drinking levels |
|---|---|---|---|
| Treatment | |||
| Received naltrexone vs. placebo naltrexone | 9 | ||
| Received CBI and MM vs. MM only | 5 | ||
| Demographic | |||
| Age | 2 | 8 | |
| Marital status | 10 | 2 | |
| Race/ethnicity | 6 | ||
| Alcohol consumption, severity, and goals | |||
| Consecutive days abstinent prior to randomization | 1 | 1 | |
| Alcohol Dependence Scale | 4 | 3 | |
| Age of onset | 5 | 10 | |
| Drinking goal | 2 | 4 | |
| WHO drinking risk levels 3 months prior to baseline | 1 | ||
| Percent days abstinent | 3 | ||
| Percent no heavy drinking | 4 | ||
| Peak blood alcohol concentration | 6 | ||
| Prior alcohol treatment | |||
| Detoxification | 5 | ||
| Alcoholics anonymous attendance | 6 | ||
| Laboratory analyses | |||
| Creatinine | 3 | 5 | |
| Total protein | 10 | 8 | 9 |
| Bilirubin | 8 | ||
| Glucose | 7 | ||
| Smoking and drug use | |||
| Current smoker | 6 | ||
| Cannabis use | |||
| Profile of Mood States (POMS) | |||
| POMS Confusions Subscale | 7 | ||
| POMS Fatigue Subscale | |||
| University of Rhode Island Change Assessment Scale | 7 | ||
| WHO Quality of Life | |||
| WHO Environmental Domain | 9 |